04:49 AM EDT, 09/29/2025 (MT Newswires) -- GSK (GSK) said Monday it has appointed Luke Miels chief executive officer designate.

Miels, who most recently served as the company's chief commercial officer, will assume the role and join the board on Jan. 1, succeeding Emma Walmsley.

Walmsley is stepping down from GSK and is planning to pursue new ventures.

Shares of GSK were up over 3% in recent Monday premarket activity.

Price: 41.20, Change: +1.35, Percent Change: +3.39